CRP and Anxiety: Thus, the current investigation focused on characterizing meaningful subtypes (i.e., clusters) of individuals according to depressive and anxiety symptomatologies, and explored whether peripheral biomarkers, including cortisol, CRP, IL-6, and TNF-α levels could be used to differentiate symptom clusters.